Prognostic Value of Hormonal Abnormalities in Heart Failure Patients

Heart Fail Clin. 2019 Jul;15(3):371-375. doi: 10.1016/j.hfc.2019.02.006. Epub 2019 Apr 5.

Abstract

The model used to explain the pathophysiologic substrate and progressive worsening in chronic heart failure (CHF) is based on the hyperactivity of renin-angiotensin-aldosterone system and adrenergic pathway. Although the neurohormonal medical approach has many advantages, it has several pitfalls, as demonstrated by high rates of CHF mortality and hospitalization. A growing body of evidence has led to the hypothesis that CHF is a multiple hormone deficiency syndrome, characterized by a reduced anabolic drive that has relevant functional and prognostic implications. The aim of this review is to summarize the evidence of reduced drive of main anabolic axes in CHF.

Keywords: Chronic heart failure; Hormonal abnormalities; Multiple hormone deficiency syndrome.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood
  • Deficiency Diseases / blood
  • Deficiency Diseases / etiology*
  • Disease Progression
  • Global Health
  • Heart Failure* / blood
  • Heart Failure* / complications
  • Heart Failure* / epidemiology
  • Hormones / blood*
  • Humans
  • Metabolic Diseases / blood
  • Metabolic Diseases / etiology*
  • Morbidity / trends
  • Prognosis

Substances

  • Biomarkers
  • Hormones